Beyond Air, Inc.
Current- Director 2019 to present
Executive record
Alpha ID: alpha:person:robert-f-careyVersion: public-0As of: 2026-10-03
Connect capital, control, accountability, and evidence.
Extensive track record in biopharmaceutical and healthcare investment banking. Previously co-founder and President of ACELYRIN, INC. and Executive Vice President and Chief Business Officer at Horizon Therapeutics plc. More than 11 years as Managing Director and Head of Life Sciences Investment Banking Group at JMP Securities.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAlpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
sec filing · Source published: Dec 19, 2025 · Retrieved: May 16, 2026
sec proxy · Source published: Dec 19, 2025 · Retrieved: Apr 25, 2026
sec filing · Source published: Jun 20, 2025 · Retrieved: May 16, 2026
sec filing · Source published: Apr 30, 2025 · Retrieved: May 16, 2026
sec proxy · Source published: Apr 30, 2025 · Retrieved: Apr 28, 2026
public source · Source published: Date unavailable · Retrieved: Date unavailable
public source · Source published: Date unavailable · Retrieved: Date unavailable
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03